产品中心 流式试剂&相关 流式抗体

所有图片(1/1)

Mouse Anti-Human CD319 Antibody (S-3010)

SLAM family member 7,CD2 subset 1,CD2-like receptor-activating cytotoxic cells (CRACC),Membrane protein FOAP-12,Novel Ly9,Protein 19A,CS1,SLAMF7

价格 600.00 1-2周
货号 S0B8459
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 宿主来源

    Mouse
  • 抗原名称

    CD319
  • 分子别名

    SLAM family member 7; CD2 subset 1; CD2-like receptor-activating cytotoxic cells (CRACC); Membrane protein FOAP-12; Novel Ly9; Protein 19A; CS1; SLAMF7
  • 细胞定位

    Membrane
  • Accession

    Q9NQ25
  • 克隆号

    S-3010
  • 抗体类型

    Mouse mAb
  • 抗体同种型

    IgG2b,k
  • 反应种属 ?

    Hu
  • 阳性样本

    human peripheral blood leukocytes
  • 纯化方式

    Protein A
  • 浓度

    2 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS pH7.4

  • 储存条件

    12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

  • 应用

    FCM

  • 稀释度

    应用 稀释度 推荐种属
    FCM 1:200 Hu
背景介绍
  • CD319, also termed SLAMF7 or CS1, is a 66 kDa self-ligating type-I trans-membrane glycoprotein of the CD2/SLAM immunoglobulin superfamily that is constitutively expressed on NK cells, activated B cells, monocytes and, at very high levels, on multiple-myeloma cells; its cytoplasmic tail contains ITSM sequences that, depending on the simultaneous presence or absence of the adaptor proteins EAT-2 and SAP, can switch between activating (via PI3K-PLCγ-ERK) and inhibitory signaling, thereby modulating NK-cell cytotoxicity, B-cell proliferation, macrophage cytokine release and antibody-dependent myeloma killing, making it both an immunomodulatory receptor and the therapeutic target of the FDA-approved monoclonal antibody elotuzumab.

  • 流式分析

    • Flow cytometric analysis of human peripheral blood leukocytes labelling Human CD319 antibody at 1/200 dilution (1 μg) / (Right panel) compared with a Mouse IgG2b, κ Isotype Control / (Left panel). Goat Anti-Mouse IgG Alexa Fluor® 647 was used as the secondary antibody. Then cells were stained with CD3 - Brilliant Violet 421™ Antibody separately.

评论(0)